Trial intelligence / Profile preview

Nebivolol vs Metoprolol succinate on endothelial function and large artery stiffness in essential hypertension

2005-001578-28Phase 4Completed

Sponsor
Menarini Group
Start
Nov 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in essential hypertension and atherosclerosis comparing Nebivolol (Nebilet) with Metoprolol succinate (Beloc-Zok) (2 arms). Started Nov 2005; status: completed.

02

Drugs

nebivololCormet
03

Conditions

essential hypertensionatherosclerosis

Beyond the preview

Go deeper on 2005-001578-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-001578-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call